fbpx

Latest News

Illumiscreen Non-Invasive Prenatal Screening – Important Information

Illumiscreen Non-Invasive Prenatal Screening Limitations of the test This test is designed to screen for chromosome aneuploidies and is validated for chromosomes 21, 18, 13 and for fetal gender. The test is validated for singleton and twin pregnancies with gestational age of at least 10 weeks 0 days, as estimated by last menstrual period, crown … Continue reading “Illumiscreen Non-Invasive Prenatal Screening – Important Information”

Latest News

COVID Can’t Stop Us

Learn how we assisted with the COVID-19 testing capacity with the Ministry of Health.

Latest News

NIPT: cost effective, first line screening for all pregnant women

The Illumiscreen prenatal test maximises cost-effectiveness with the lowest failure rate.

Latest News

Highlights From ACOG-SMFM

What is new in DNA screening?

Latest News

Technology of Choice

Data shows Illumina next-generation sequencing is the NIPT technology of choice.

Latest News

Accurate and Reliable Testing

Accurate and Reliable Testing The Illumiscreen prenatal test uses proven NGS technology to provide accurate NIPT results with the lowest failure rate What is test failure? For noninvasive prenatal testing (NIPT), test failure indicates that no call for chromosomal status can be made. This is an important factor in the reliability and clinical utility of … Continue reading “Accurate and Reliable Testing”